<SEC-DOCUMENT>0001140361-26-006721.txt : 20260225
<SEC-HEADER>0001140361-26-006721.hdr.sgml : 20260225
<ACCEPTANCE-DATETIME>20260225073036
ACCESSION NUMBER:		0001140361-26-006721
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20260225
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260225
DATE AS OF CHANGE:		20260225

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Immunocore Holdings plc
		CENTRAL INDEX KEY:			0001671927
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39992
		FILM NUMBER:		26674209

	BUSINESS ADDRESS:	
		STREET 1:		90 PARK DRIVE
		STREET 2:		MILTON PARK, ABINGDON
		CITY:			OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RY
		BUSINESS PHONE:		01235 5430281

	MAIL ADDRESS:	
		STREET 1:		90 PARK DRIVE
		STREET 2:		MILTON PARK, ABINGDON
		CITY:			OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RY

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Immunocore Ltd
		DATE OF NAME CHANGE:	20160412
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ef20066378_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2025" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:imcr="http://immunocore.com./20260225" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Disclosure
         Document created using Broadridge PROfile 25.10.1.5333
         Copyright 1995 - 2026 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_250538e4e821412e857745bc004b128e" contextRef="c20260225to20260225" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_aaa86321ccf34829809414b68f47ebe3" contextRef="c20260225to20260225">0001671927</ix:nonNumeric><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_86c07db62f8542e7b5266aa6f5508736" contextRef="c20260225to20260225">X0</ix:nonNumeric><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_7179d905fcd44be2b3fd3063d7f063d1" contextRef="c20260225to20260225">00-0000000</ix:nonNumeric><ix:nonNumeric name="dei:Security12bTitle" id="Fact_c7bfe0d81bf84bf5a97521cc0706e5c2" contextRef="c20260225to20260225_StatementClassOfStockAxis_OrdinaryShareNominalValue0002PerShareMember">Ordinary share, nominal value 0.002 per share*</ix:nonNumeric><ix:nonNumeric name="dei:Security12bTitle" id="Fact_0dd69d95358a451387bd6a571bd44601" contextRef="c20260225to20260225_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember">American Depositary Shares, each representing one ordinary share, nominal value 0.002 per share</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_f5b67d1627e34a4bbe6fd8cefafe48ad" contextRef="c20260225to20260225_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember">NASDAQ</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_e83551897f1e440e9796e1c0055b6589" contextRef="c20260225to20260225_StatementClassOfStockAxis_OrdinaryShareNominalValue0002PerShareMember">NASDAQ</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="imcr-20260225.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20260225to20260225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671927</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-02-25</xbrli:startDate><xbrli:endDate>2026-02-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20260225to20260225_StatementClassOfStockAxis_OrdinaryShareNominalValue0002PerShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671927</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">imcr:OrdinaryShareNominalValue0002PerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-02-25</xbrli:startDate><xbrli:endDate>2026-02-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20260225to20260225_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671927</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">imcr:AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-02-25</xbrli:startDate><xbrli:endDate>2026-02-25</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
<div style="line-height: initial;">
  <div><span style="font-size: 10pt;"> </span></div>

  <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
  <div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">WASHINGTON, D.C. 20549</div>

    <div style="font-size: 10pt;"><br/>
    </div>

    <div style="font-size: 10pt;">
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_e23b7feba4c04796a5574f4a8af8c894" contextRef="c20260225to20260225">8-K</ix:nonNumeric></div>

    <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <div style="font-size: 10pt;">
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    <div style="font-size: 10pt;"><br/>
    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d)</div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">of the Securities Exchange Act of 1934</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_f302ce8a6b1c4c3997c4675c23c8e08b" contextRef="c20260225to20260225" format="ixt:date-monthname-day-year-en">February 25, 2026</ix:nonNumeric></div>

    <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <div style="font-size: 10pt;">
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_93cc693ce62a43b09d93566efbbbe079" contextRef="c20260225to20260225">Immunocore Holdings plc</ix:nonNumeric><br/>
    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Exact name of registrant as specified in its Charter)</div>

    <div style="font-size: 10pt;"><br/>
    </div>

    <div style="font-size: 10pt;">
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 33%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><span style="text-decoration: underline;"><span style="-sec-ix-hidden:Fact_86c07db62f8542e7b5266aa6f5508736">England and Wales </span></span></div>
          </td>

    <td style="width: 34%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><span style="text-decoration: underline;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_d788b2009e2d4a44bf2c87af794fd482" contextRef="c20260225to20260225">001-39992</ix:nonNumeric></span></div>
          </td>

    <td style="width: 33%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><span style="text-decoration: underline;"><span style="-sec-ix-hidden:Fact_7179d905fcd44be2b3fd3063d7f063d1">Not Applicable </span></span></div>
          </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(State or other jurisdiction of incorporation)</div>
          </td>

    <td style="width: 34%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(Commission File Number)</div>
          </td>

    <td style="width: 33%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(IRS Employer Identification No.)</div>
          </td>

  </tr>


</table>
    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_d5a72c77266746dab47419523eb1df5c" contextRef="c20260225to20260225">92 Park Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_53ca2562655b41c1ad778b400382b2d9" contextRef="c20260225to20260225">Milton Park Abingdon</ix:nonNumeric>,</div>
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_d2b5b2226fda4b339e97303895c86c7e" contextRef="c20260225to20260225">Oxfordshire</ix:nonNumeric>,</div>
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCountry" id="Fact_8d3af2bb6356495c9cc65a6dbe8d6bb4" contextRef="c20260225to20260225" format="ixt-sec:countrynameen">United Kingdom</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_bb8c106e83c849a3887c88dd687313ca" contextRef="c20260225to20260225">OX14 4RY</ix:nonNumeric></div>
          </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(Address of principal executive offices)</div>
          </td>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(Zip Code)</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;"><br/>
    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">+<ix:nonNumeric name="dei:CityAreaCode" id="Fact_ce298ce5ed4e435cbaea2c44a8c9a761" contextRef="c20260225to20260225">44</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_18f38d71fc25434d951736506b997daf" contextRef="c20260225to20260225">1235 438600</ix:nonNumeric></div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Registrant&#8217;s telephone number, including area code)</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Not Applicable</div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Former name or former address, if changed since last report)</div>

    <div style="font-size: 10pt;"><br/>
    </div>

    <div style="text-align: center;">
<div><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;"> </span></div>

      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
      following provisions:</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_a90f31d7a32e4b719ed00dd335e70382" contextRef="c20260225to20260225" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
          </td>

  </tr>


</table>
    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_1c28b9b01f6846228baffa5c5167350a" contextRef="c20260225to20260225" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
          </td>

  </tr>


</table>
    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_becc57570dc24a858fb71d0f72e68a95" contextRef="c20260225to20260225" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
          </td>

  </tr>


</table>
    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_2cbe863c27904828917a5ab056f8f822" contextRef="c20260225to20260225" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;"><br/>
    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

    <div style="font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 62.17%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Title of each class</div>
          </td>

    <td style="width: 9.15%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Trading</div>
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Symbol(s)</div>
          </td>

    <td style="width: 28.69%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Name of each exchange on</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">which registered</div>
          </td>

  </tr>

  <tr>

    <td style="width: 62.17%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><span style="-sec-ix-hidden:Fact_0dd69d95358a451387bd6a571bd44601">American Depositary Shares, each representing one ordinary share, nominal value &#163;0.002 per share</span></div>
          </td>

    <td style="width: 9.15%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_a9217c04979844f284d18665a6b3393e" contextRef="c20260225to20260225_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember">IMCR</ix:nonNumeric></div>
          </td>

    <td style="width: 28.69%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><span style="-sec-ix-hidden:Fact_f5b67d1627e34a4bbe6fd8cefafe48ad">The Nasdaq Stock Market LLC</span></div>
          </td>

  </tr>

  <tr>

    <td style="width: 62.17%; vertical-align: bottom; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><span style="-sec-ix-hidden:Fact_c7bfe0d81bf84bf5a97521cc0706e5c2">Ordinary share, nominal value &#163;0.002 per share*</span></div>
          </td>

    <td style="width: 9.15%; vertical-align: bottom; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_433ceee7fb7d4e898fcd3dd8e70b2c40" contextRef="c20260225to20260225_StatementClassOfStockAxis_OrdinaryShareNominalValue0002PerShareMember">*</ix:nonNumeric></div>
          </td>

    <td style="width: 28.69%; vertical-align: bottom; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">
            <div style="text-align: center;"><span style="-sec-ix-hidden:Fact_e83551897f1e440e9796e1c0055b6589">The Nasdaq Stock Market LLC</span></div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">* <span style="font-family: 'Times New Roman'; font-style: italic;">Not for trading, but only in connection with the listing of the American Depositary
        Shares on The Nasdaq Stock Market LLC.</span></div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter)
      or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

    <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_cd6b97acb2964620807e60199338d126" contextRef="c20260225to20260225" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
      revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

    <div style="font-size: 10pt;"><br/>
    </div>

    <div style="font-size: 10pt;">
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 2.02.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Results of Operations and Financial Condition.</div>
          </td>

  </tr>


</table>
    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <div style="text-align: left; text-indent: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On February 25, 2026, Immunocore Holdings plc (the &#8220;Company&#8221;) issued a press release announcing its financial results for the fourth
      quarter and full year ended December 31, 2025, as well as other recent corporate updates. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <div style="text-align: left; text-indent: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The information in this Item 2.02 of this Current Report on 8-K, including Exhibits 99.1 hereto, is being furnished and shall not be
      deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any of the Company&#8217;s
      filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific references in
      such filing.</div>

    <div style="font-size: 10pt;"><br/>
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 105.25pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Financial Statements and Exhibits</div>
          </td>

  </tr>


</table>
    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0); border-spacing: 0;">


  <tr>

    <td style="width: 10%; vertical-align: bottom; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><span style="text-decoration: underline;">Exhibit No.</span></div>
          </td>

    <td style="width: 90%; vertical-align: bottom; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><span style="text-decoration: underline;">Description</span></div>
          </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><a href="ef20066378_ex99-1.htm">99.1</a></div>
          </td>

    <td style="width: 90%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; text-indent: 1.7pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Press Release dated February 25, 2026.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">104</div>
          </td>

    <td style="width: 90%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; text-indent: 1.7pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Cover Page Interactive Data File (embedded within the Inline XBRL document).</div>
          </td>

  </tr>


</table>
    <div style="text-align: left; font-size: 10pt;"><br/>
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by
      the undersigned hereunto duly authorized.</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>

    <td colspan="2" style="vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">IMMUNOCORE HOLDINGS PLC</div>
          </td>

  </tr>

  <tr>

    <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>

    <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td colspan="2" style="vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Dated: February 25, 2026</div>
          </td>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">By:</div>
          </td>

    <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">/s/ Bahija Jallal, Ph.D.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 48%; vertical-align: top; font-size: 10pt;">Name:</td>

    <td colspan="2" rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Bahija Jallal, Ph.D.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 48%; vertical-align: top; font-size: 10pt;">Title:</td>

    <td colspan="2" rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Chief Executive Officer</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <div style="font-size: 10pt;">
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

  </div>

  <div><span style="font-size: 10pt;"> </span></div>

</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ef20066378_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Disclosure
         Document created using Broadridge PROfile 25.10.1.5333
         Copyright 1995 - 2026 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="color: rgb(0, 0, 0); font-size: 10pt;"> </font>
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"><font style="color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">Exhibit
    99.1</font><font style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </font>
  <div style="text-align: center; margin-left: 3.3pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;Immunocore reports fourth quarter and full year 2025 financial results and provides a business update</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">KIMMTRAK (tebentafusp-tebn) Q4 net sales of $104.5 million and $400.0 million for full year 2025; expect moderating revenue growth
    in 2026</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">TEBE-AM enrollment completion anticipated 1H 2026 with topline data expected as early as 2H 2026</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">PRAME franchise Phase 1/2 data to be presented in 2H 2026: brenetafusp in ovarian and lung cancer, and initial data with half-life
    extended candidate (IMC-P115C)</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Additional Phase 1 HIV data to be presented in 2H 2026</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Cash, cash equivalents and marketable securities of $864.2 million as of December 31, 2025</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Conference call today, February 25 at 8:00AM ET, 1:00 PM GMT</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">(<font style="font-family: 'Times New Roman';">OXFORDSHIRE, England &amp; RADNOR, Penn. &amp; GAITHERSBURG, Md., US, 25</font> February 2026) <u>Immunocore


      Holdings plc (Nasdaq: IMCR) (&#8220;Immunocore&#8221; or the &#8220;Company&#8221;)</u>, a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases
    and autoimmune diseases, today announced its financial results for the fourth quarter and year ended December 31, 2025, and provided a business update.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">The Company has demonstrated commercial momentum with 15 consecutive quarters of KIMMTRAK<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (tebentafusp-tebn) revenue growth, driven by US community and global market penetration. In addition, the Company is preparing for potential new melanoma indications as it enrolls three Phase 3 trials: TEBE-AM and ATOM,
    delivering on KIMMTRAK&#8217;s lifecycle management, and PRISM-MEL-301 evaluating brenetafusp in first-line melanoma. Enrollment in the late-line cutaneous melanoma trial (TEBE-AM) remains on track for completion in the first half of this year with topline
    overall survival (OS) data as early as the second half of 2026.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">The Company continued to advance its clinical pipeline beyond melanoma into other tumor types enrolling patients across multiple early-stage trials.
    In the second half of 2026, the Company expects to present data from the ongoing ovarian and NSCLC expansion cohorts of the Phase 1/2 trial of brenetafusp and the initial data from the half-life extended PRAME-A02 candidate (IMC-P115C).</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">The Company is progressing on its growth opportunities beyond oncology, as it continues to dose escalate in the HIV functional cure program and plans
    to enter the clinic with its first autoimmune candidate in the first half of this year. The Company&#8217;s strong balance sheet provides the financial flexibility to execute these programs.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">&#8220;With $400 million in KIMMTRAK sales and a diverse clinical portfolio, Immunocore had a productive year of growth and progress in 2025,&#8221; <font style="font-family: 'Times New Roman'; font-weight: bold;">said Bahija Jallal, CEO of Immunocore</font>. &#8220;Our priority for 2026 is the clear execution of our clinical trials, particularly as we anticipate key data in oncology and begin our first
    trial in autoimmune disease. We remain focused on the long-term goal of developing medicines that can significantly improve patient lives."</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;">
    <div><br>
    </div>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Full Year and Fourth Quarter Highlights (including post-period)</u></div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; color: rgb(0, 0, 0);">Financial Results</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">For the fourth quarter of 2025 (Q4 2025), total net product revenue (or &#8216;net sales&#8217;) arising from the sales of KIMMTRAK was $104.5 million, <font style="font-family: 'Times New Roman';">compared to $84.1 million for the same period in 2024.</font> Q4 2025 sales were $69.0 million in the United States, $32.1 million in Europe, and $3.4 million in international regions.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">For the year ended December 31, 2025 (FY 2025), net sales of KIMMTRAK were $400.0 million, <font style="font-family: 'Times New Roman';">compared to
      $310.0 million for the same period in 2024. FY 2025 </font>sales <font style="font-family: 'Times New Roman';">were </font>$257.0 million in the United States, $131.4 million in Europe and $11.6 million in international regions. For both the Q4
    2025 and FY 2025, <font style="font-family: 'Times New Roman';">the increases in net product sales were due to increased volumes in the United States and Europe as well as global country expansion.</font></div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Research &amp; development (R&amp;D) expenses for Q4 2025 were $78.8 million, compared to $60.9 million for Q4 2024. R&amp;D expenses for FY 2025 were
    $274.9 million, compared to $222.2 million for FY 2024. <font style="font-family: 'Times New Roman';">These increases were due to preclinical expenses related to the advancement of the Company&#8217;s autoimmune programs, including clinical material
      manufacturing for anticipated Phase 1 initiations, and due to clinical expenses related to the progression of our Phase 3 trials, primarily TEBE-AM and PRISM-MEL-301.</font></div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Selling, general and administrative (SG&amp;A) expenses for Q4 2025 were $42.6 million, compared to $42.3 million for Q4 2024. SG&amp;A expenses for
    FY 2025 were $165.4 million, compared to $155.8 million for FY 2024. <font style="font-family: 'Times New Roman';">These increases were primarily due to costs related to commercial and business support functions to support our growing pipeline and
      global commercial expansion.</font></div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Net loss for Q4 2025 was $30.1 million compared to a net loss of $23.8 million for Q4 2024, and full year net loss for 2025 was $35.5 million compared
    to a full year net loss of $51.1 million in 2024.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">The Q4 2025 basic and diluted loss per share was $0.60 compared to $0.47 for Q4 2024. Basic and diluted loss per share for FY 2025 was $0.71, compared
    to $1.02 for FY 2024.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cash, cash equivalents and marketable securities were $864.2 million as of December 31, 2025, as compared to $820.4 million as of December 31, 2024.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>KIMMTRAK</u></div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; color: rgb(0, 0, 0);">The Company&#8217;s lead product, KIMMTRAK<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>
    (tebentafusp), is approved in 39 countries and has been launched in 30 countries globally to date for HLA-A*02:01 positive people with unresectable or metastatic uveal melanoma (mUM). KIMMTRAK continues to be the standard of care in most markets where
    it is launched.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; color: rgb(0, 0, 0);">The Company sees three key growth areas as it plans to expand patient reach for KIMMTRAK, including continued US community and
    global market penetration in mUM, the potential expansion into 2L+ advanced cutaneous melanoma (CM), and the potential expansion into adjuvant uveal melanoma.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; color: rgb(0, 0, 0);">Metastatic uveal melanoma</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8bebb896f5b64e19a7cb6b3c2ac44462">

      <tr>
        <td style="width: 18pt; color: rgb(0, 0, 0); font-size: 10pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">KIMMTRAK net product sales were $104.5 million and $400.0 million for the fourth quarter and year ended December 31, 2025, respectively, representing increases of 24% and 29% respectively, as compared
            to the same periods in 2024.</div>
        </td>
      </tr>

  </table>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd65178b80a364e2886cbb0abedbe3e1f">

      <tr>
        <td style="width: 18pt; color: rgb(0, 0, 0); font-size: 10pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">13% year-over-year sales growth in the United States with mean duration of treatment increasing to 14 months.</div>
        </td>
      </tr>

  </table>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbb31c82833e44cd0b1bbc6824e7b680a">

      <tr>
        <td style="width: 18pt; color: rgb(0, 0, 0); font-size: 10pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">79% year-over-year sales growth in Europe, driven by increased demand and launches in European markets.</div>
        </td>
      </tr>

  </table>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; color: rgb(0, 0, 0);">2L+ advanced cutaneous melanoma</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z97bf3eca629e47e486c954675cee0cce">

      <tr>
        <td style="width: 18pt; color: rgb(0, 0, 0); font-size: 10pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">The Company is currently enrolling patients in the TEBE-AM registrational Phase 3 trial and expects to complete enrollment in the first half of 2026 with topline data expected as early as the second
            half of 2026.</div>
        </td>
      </tr>

  </table>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z79ab740760494865a998407f04e6dd73">

      <tr>
        <td style="width: 18pt; color: rgb(0, 0, 0); font-size: 10pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">The Phase 3 trial is enrolling three arms: tebentafusp monotherapy, tebentafusp in combination with pembrolizumab, and a control (investigator's choice of therapy including clinical trials,
            chemotherapy, or retreatment with anti-PD1 or BRAF therapy). The primary endpoint of the randomized Phase 3 trial is Overall Survival (OS).</div>
        </td>
      </tr>

  </table>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze540e5b97dbf43a2a7abb3e295c6bf64">

      <tr>
        <td style="width: 18pt; color: rgb(0, 0, 0); font-size: 10pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">There is great unmet need in second- and later-line cutaneous melanoma, with no therapy having shown, to date, an OS improvement post checkpoint inhibitors in a randomized clinical trial. The Company
            estimates that there is a potential to address up to 4,000 previously treated advanced HLA-A*02:01 positive CM patients.</div>
        </td>
      </tr>

  </table>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; color: rgb(0, 0, 0);">Adjuvant uveal (or ocular) melanoma</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7fba284057fd40b9809fe4e05aaa3f55">

      <tr>
        <td style="width: 18pt; color: rgb(0, 0, 0); font-size: 10pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">The European Organisation for Research and Treatment of Cancer (EORTC) continues to expand the site footprint of the Phase 3 Adjuvant Trial in Ocular Melanoma (ATOM).</div>
        </td>
      </tr>

  </table>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8869e2fe3bb8450496342d2bc7a8273e">

      <tr>
        <td style="width: 18pt; color: rgb(0, 0, 0); font-size: 10pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">The Company estimates that the HLA-A*02:01 positive, high-risk adjuvant uveal melanoma patient population could be up to 1,200 patients in the US and Europe.</div>
        </td>
      </tr>

  </table>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>PRAME portfolio</u></div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; color: rgb(0, 0, 0);">Brenetafusp is the Company&#8217;s lead PRAME-A02 ImmTAC bispecific candidate. Brenetafusp is being evaluated in combination with
    nivolumab in a Phase 3 registrational trial (PRISM-MEL-301) in patients with first-line, advanced cutaneous melanoma, and in a Phase 1/2 clinical trial as monotherapy and in combination across multiple tumor types, including ovarian cancer and
    non-small cell lung cancer (NSCLC).</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; color: rgb(0, 0, 0);">PRISM-MEL-301 &#8211; First PRAME Phase 3 clinical trial with brenetafusp in first-line advanced cutaneous melanoma</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za2fadb7cc54d4ae888ecca62d539858b">

      <tr>
        <td style="width: 18pt; color: rgb(0, 0, 0); font-size: 10pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-size: 10pt;"><a name="z_Hlk211934807"></a><font style="font-family: 'Times New Roman';">&#8226;</font></td>
        <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">In November 2025, the Independent Data Monitoring Committee (IDMC) recommended the dose of 160 mcg as the go-forward dose in PRISM-MEL-301, the Company&#8217;s registrational Phase 3 trial in first-line,
            advanced cutaneous melanoma.</div>
        </td>
      </tr>

  </table>
  <div> <br>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb24c8056a6dc4f7290b96b6c74e82373">

      <tr>
        <td style="width: 18pt; color: rgb(0, 0, 0); font-size: 10pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">The Company continues with a 1:1 randomization of HLA-A*02:01 positive patients with first-line, advanced or metastatic cutaneous melanoma to brenetafusp 160 mcg + nivolumab or a control arm of either
            nivolumab or nivolumab + relatlimab.</div>
        </td>
      </tr>

  </table>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2d737c9098924ac095ae28bbd022c96b">

      <tr>
        <td style="width: 18pt; color: rgb(0, 0, 0); font-size: 10pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">Despite approved therapies, there remains a need for improved progression-free survival and OS, and there is the potential to address an estimated 10,000 HLA-A*02:01 positive patients in the US and
            Europe.</div>
        </td>
      </tr>

  </table>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; color: rgb(0, 0, 0);">Phase 1/2 clinical trials of brenetafusp and IMC-P115C (PRAME-A02 Half-Life Extended) in multiple solid tumors</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7d22cf49b20b4b388a188ecf928c9b35">

      <tr>
        <td style="width: 18pt; color: rgb(0, 0, 0); font-size: 10pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">The Company continues to evaluate brenetafusp in a Phase 1/2 trial in combination in platinum-resistant ovarian cancer (PROC) and in earlier lines of platinum-sensitive ovarian cancer (PSOC). In the
            same trial, the Company continues signal detection in metastatic non-small cell lung cancer (NSCLC) cohorts, including combination in earlier-line NSCLC.</div>
        </td>
      </tr>

  </table>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z069e2d05a4c34edd92c29df9e7ed0a6c">

      <tr>
        <td style="width: 18pt; color: rgb(0, 0, 0); font-size: 10pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">The Company is enrolling patients in the Phase 1 dose escalation trial evaluating IMC-P115C in patients with multiple solid tumors.</div>
        </td>
      </tr>

  </table>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8c012fade26f4f23b6c40cac2ebef5a3">

      <tr>
        <td style="width: 18pt; color: rgb(0, 0, 0); font-size: 10pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">The Company expects to present Phase 1/2 data from both trials in the second half of 2026.</div>
        </td>
      </tr>

  </table>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>IMC-R117C (PIWIL1) for colorectal and other gastrointestinal cancers</u></div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z515d54976ad643b2b3d3cbef9ad38ad6">

      <tr>
        <td style="width: 18pt; color: rgb(0, 0, 0); font-size: 10pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">The Company is enrolling patients in the Phase 1/2 dose escalation trial evaluating IMC-R117C in HLA-A*02:01 positive patients with advanced solid tumors, including colorectal cancer, as a single agent
            and in combination with standards of care.</div>
        </td>
      </tr>

  </table>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze80668af21ce434c9ea994f5d6844e34">

      <tr>
        <td style="width: 18pt; color: rgb(0, 0, 0); font-size: 10pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">The Company expects to present initial data in 2027.</div>
        </td>
      </tr>

  </table>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>ImmTAV candidates for a functional cure in infectious diseases</u></div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; color: rgb(0, 0, 0);">The Company&#8217;s bispecific TCR technology platform has the potential to offer a new approach for the treatment of certain chronic
    infections and aims to eliminate evidence of remaining virus in circulation after the patient stops taking medication &#8211; known as a &#8216;functional cure&#8217;. The Company is studying an investigational candidate for people living with human immunodeficiency
    virus (HIV). The Company has completed the single ascending dosing in the Phase 1 study for its chronic hepatitis B infection (HBV) program and is evaluating next steps.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; color: rgb(0, 0, 0);">Phase 1/2 trial of IMC-M113V (Gag-A02) for people living with HIV</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zda9ab8ec6fb94f2c8b00037a5a3c4543">

      <tr>
        <td style="width: 18pt; color: rgb(0, 0, 0); font-size: 10pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">Patient enrollment continues at higher doses in the multiple ascending dose part of the Phase 1/2 clinical trial to identify a safe and tolerable dose.</div>
        </td>
      </tr>

  </table>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0d9082c2672c433995704b5555668aed">

      <tr>
        <td style="width: 18pt; color: rgb(0, 0, 0); font-size: 10pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">The Company published the single ascending dose data in a manuscript in <font style="font-family: 'Times New Roman'; font-style: italic;">Nature Communications</font>.</div>
        </td>
      </tr>

  </table>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z039cca3651814fc99bd7f78cd2a4ca02">

      <tr>
        <td style="width: 18pt; color: rgb(0, 0, 0); font-size: 10pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">Additional Phase 1 data to be presented in the second half of 2026</div>
        </td>
      </tr>

  </table>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;">
    <div><br>
    </div>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Tissue-specific down modulation of the immune system for autoimmune diseases</u></div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; color: rgb(0, 0, 0);">The key differentiator of the ImmTAAI platform is tissue-specific, down modulation of the immune system, as the candidates
    suppress pathogenic T cells via PD1 receptor agonism only when tethered to the target tissue.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4e434cb1fdb24210b4d63c4d4541bdb1">

      <tr>
        <td style="width: 18pt; color: rgb(0, 0, 0); font-size: 10pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">The Company filed a clinical trial application (CTA) for IMC-S118AI (PPI x PD1) in December 2025 and expects to begin the Phase 1 trial in the first half of 2026.</div>
        </td>
      </tr>

  </table>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2959d19420bc4d37868bcb7b4d4beaf2">

      <tr>
        <td style="width: 18pt; color: rgb(0, 0, 0); font-size: 10pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">The Company plans to file a CTA or investigational new drug (IND) application for IMC-U120AI (CD1a x PD1) in the second half of 2026.</div>
        </td>
      </tr>

  </table>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;">
    <div style="text-align: center; font-family: 'Times New Roman';">###</div>
  </div>
  <div>
    <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
    </div>
  </div>
  <div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About ImmTAC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> molecules for cancer</div>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Immunocore&#8217;s proprietary T cell receptor (TCR) technology generates a novel class of bispecific biologics called ImmTAC (Immune mobilizing monoclonal
    TCRs Against Cancer) molecules that are designed to redirect the immune system to recognize and kill cancerous cells. ImmTAC molecules are soluble TCRs engineered to recognize intracellular cancer antigens with ultra-high affinity and selectively kill
    these cancer cells via an anti-CD3 immune-activating effector function. Based on the demonstrated mechanism of T cell infiltration into human tumors, the ImmTAC mechanism of action holds the potential to treat hematologic and solid tumors, regardless
    of mutational burden or immune infiltration, including immune &#8220;cold&#8221; low mutation rate tumors.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;">
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">About ImmTAV<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> molecules and infectious diseases</div>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">ImmTAV (Immune mobilizing monoclonal TCRs Against Virus) molecules are novel bispecifics that are designed to enable the immune system to recognize
    and eliminate virally infected cells. Immunocore is advancing clinical candidates to cure patients with HIV and hepatitis B virus (HBV). The Company aims to achieve sustained control of HIV after patients stop anti-retroviral therapy (ART), without the
    risk of virological relapse or onward transmission. This is known as &#8216;functional cure&#8217;. For the treatment of HBV, the Company aims to achieve sustained loss of circulating viral antigens and markers of viral replication after stopping medication for
    people living with chronic HBV.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;">
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">About ImmTAAI<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> molecules and autoimmune diseases</div>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">ImmTAAI (Immune mobilizing monoclonal TCRs Against AutoImmune disease) molecules are novel bispecifics that are designed for tissue-specific down
    modulation of the immune system. When tethered to the tissue of interest, ImmTAAI candidates suppress pathogenic T cells via PD1 receptor agonism. The Company is currently advancing two candidates for autoimmune diseases, including type 1 diabetes and
    inflammatory dermatological diseases.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;">
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">About PRISM-MEL-301 (NCT06112314) &#8211; Phase 3 trial with brenetafusp (IMC-F106C, PRAME-A02) in 1L advanced cutaneous melanoma</div>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">The Phase 3 registrational trial is randomizing HLA-A*02:01-positive patients with previously untreated, advanced or metastatic cutaneous melanoma, to
    brenetafusp 160 mcg + nivolumab or a control arm of either nivolumab or nivolumab + relatlimab. The brenetafusp dose of 160 mcg was recommended by the Independent Data Monitoring Committee, following a pre-planned review of safety for all three arms
    and of efficacy for the two brenetafusp regimens (40 mcg and 160 mcg) in the first 90 patients randomized in the Phase 3 trial. The primary endpoint of the trial is progression free survival (PFS) by blinded independent central review (BICR), with
    secondary endpoints of overall survival (OS) and overall response rate (ORR).</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;">
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">About the IMC-F106C-101 Phase 1/2 trial</div>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">IMC-F106C-101 is a first-in-human, Phase 1/2 dose escalation trial in patients with multiple solid tumors, including non-small cell lung and ovarian
    cancers. The Phase 1 dose escalation trial was designed to determine the maximum tolerated dose (MTD), as well as to evaluate the safety, preliminary anti-tumor activity and pharmacokinetics of IMC-F106C (brenetafusp), a bispecific protein built on
    Immunocore&#8217;s ImmTAC technology, and the Company&#8217;s first molecule to target the PRAME antigen. The Company is currently focusing on enrolling patients in combination arms with standards-of-care across multiple tumor types.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;">
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">About TEBE-AM &#8211; Phase 3 registrational trial with tebentafusp in previously treated advanced cutaneous melanoma</div>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">The trial is randomizing patients with second-line or later advanced cutaneous melanoma who have progressed on an anti-PD1, received prior ipilimumab
    and, if applicable, received a BRAF kinase inhibitor. Patients are randomized to one of three arms, including tebentafusp &#8211; as monotherapy or in combination with an anti-PD1 &#8211; or a control arm. The primary endpoint is overall survival.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;">
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">About the ATOM Phase 3 trial</div>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">The EORTC-sponsored Phase 3 clinical trial will include sites in 10 EU countries and the United States and is randomizing HLA-A*02:01-positive
    patients with high-risk primary uveal melanoma after definitive treatment, by surgery or radiotherapy, and no evidence of metastatic disease on imaging. The trial is expected to enroll a total of 290 patients who will be randomized 1:1 to one of two
    arms: tebentafusp as monotherapy or observation. The primary endpoint of the trial is relapse-free survival (RFS), with secondary objectives of overall survival and safety and tolerability of tebentafusp. Exploratory objectives include the comparison
    of the health-related quality of life between the treatment arms and the evaluation of the role of circulating tumor DNA (ctDNA) as a biomarker for the presence of residual disease.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;">
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">About Uveal Melanoma</div>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Uveal melanoma is a rare and aggressive form of melanoma, which affects the eye. This is the most common primary intraocular malignancy in adults and
    up to 50% of people with uveal melanoma will eventually develop metastatic disease. Unresectable or metastatic uveal melanoma typically has a poor prognosis and had no approved treatment until KIMMTRAK.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;">
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">About Cutaneous Melanoma</div>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Cutaneous melanoma (CM) is the most common form of melanoma. It is the most aggressive skin carcinoma and is associated with the vast majority of skin
    cancer-related mortality. The majority of patients with CM are diagnosed before metastasis but survival remains poor for the large proportion of patients with metastatic disease. Despite recent progress in advanced melanoma therapy, there is still an
    unmet need for new therapies that improve first-line response rates and duration of response as well as for patients who are refractory to first-line treatments.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;">
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">About KIMMTRAK<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">KIMMTRAK is a novel bispecific protein comprised of a soluble T cell receptor fused to an anti-CD3 immune-effector function. KIMMTRAK specifically
    targets gp100, a lineage antigen expressed in melanocytes and melanoma. This is the first molecule developed using Immunocore&#8217;s ImmTAC technology platform, designed to redirect and activate T cells to recognize and kill tumor cells. KIMMTRAK has been
    approved for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma in the United States, European Union, Canada, Australia, and the United Kingdom.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;">
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">IMPORTANT SAFETY INFORMATION</div>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Cytokine Release Syndrome (CRS), which may be serious or
      life-threatening, occurred in patients receiving KIMMTRAK. Monitor for at least 16 hours following first three infusions and then as clinically indicated.</font><font style="color: rgb(0, 0, 0); font-size: 10pt;"> Manifestations of CRS may include
      fever, hypotension, hypoxia, chills, nausea, vomiting, rash, elevated transaminases, fatigue, and headache. CRS occurred in 89% of patients who received KIMMTRAK, with 0.8% being grade 3 or 4. Ensure immediate access to medications and resuscitative
      equipment to manage CRS. Ensure patients are euvolemic prior to initiating the infusions. Closely monitor patients for signs or symptoms of CRS following infusions of KIMMTRAK. Monitor fluid status, vital signs, and oxygenation level and provide
      appropriate therapy. Withhold or discontinue KIMMTRAK depending on persistence and severity of CRS.</font></div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Skin Reactions</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Skin reactions, including rash, pruritus, and cutaneous edema occurred in 91% of patients treated with KIMMTRAK. Monitor patients for skin reactions.
    If skin reactions occur, treat with antihistamine and topical or systemic steroids based on persistence and severity of symptoms. Withhold or permanently discontinue KIMMTRAK depending on the severity of skin reactions.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Elevated Liver Enzymes</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Elevations in liver enzymes occurred in 65% of patients treated with KIMMTRAK. Monitor alanine aminotransferase (ALT), aspartate aminotransferase
    (AST), and total blood bilirubin prior to the start of and during treatment with KIMMTRAK. Withhold KIMMTRAK according to severity.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Embryo-Fetal Toxicity</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">KIMMTRAK may cause fetal harm. Advise pregnant patients of potential risk to the fetus and patients of reproductive potential to use effective
    contraception during treatment with KIMMTRAK and 1 week after the last dose.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">The most common adverse reactions (&#8805;30%) in patients who received KIMMTRAK were cytokine release syndrome, rash, pyrexia, pruritus, fatigue, nausea,
    chills, abdominal pain, edema, hypotension, dry skin, headache, and vomiting. The most common (&#8805;50%) laboratory abnormalities were decreased lymphocyte count, increased creatinine, increased glucose, increased AST, increased ALT, decreased hemoglobin,
    and decreased phosphate.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">For more information, please see full Summary of Product Characteristics (SmPC) or full U.S. Prescribing Information (including BOXED WARNING for
    CRS).</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;">
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">About KIMMTRAKConnect</div>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Immunocore is committed to helping patients who need KIMMTRAK obtain access via its KIMMTRAKConnect program. The US program provides services with
    dedicated nurse case managers who provide personalized support, including educational resources, financial assistance, and site of care coordination. To learn more, visit KIMMTRAKConnect.com or call 844-775-2273.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;">
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">About Immunocore</div>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Immunocore is a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX &#8211;
    Immune mobilizing monoclonal TCRs Against X disease &#8211; designed to treat a broad range of diseases, including cancer, autoimmune diseases and infectious diseases. Leveraging its proprietary, flexible, off-the-shelf ImmTAX platform, Immunocore is
    developing a deep pipeline in multiple therapeutic areas, including clinical and pre-clinical programs&#8203; in oncology, infectious diseases, and autoimmune diseases. The Company&#8217;s most advanced oncology TCR therapeutic, KIMMTRAK, has been approved for the
    treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma in the United States, European Union, Canada, Australia, and the United Kingdom.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;">
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">Forward Looking Statements</div>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">This press release contains &#8220;forward-looking statements&#8221; within the meaning of the safe harbor provisions of the Private Securities Litigation Reform
    Act of 1995. Words such as &#8220;may&#8221;, &#8220;will&#8221;, &#8220;believe&#8221;, &#8220;expect&#8221;, &#8220;plan&#8221;, &#8220;anticipate&#8221;, &#8220;aim&#8221;, &#8220;continue&#8221;, &#8220;target&#8221; and similar expressions (as well as other words or expressions referencing future events or circumstances) are intended to identify
    forward-looking statements. All statements, other than statements of historical facts, included in this press release are forward-looking statements. These statements include, but are not limited to, statements regarding the Company&#8217;s ability to reach
    more patients for KIMMTRAK, including continued U.S. community and global market penetration in mUM, the potential expansion into 2L+ advanced cutaneous melanoma, and the potential expansion into adjuvant uveal melanoma, and to deliver on KIMMTRAK&#8217;s
    lifecycle management; the Company&#8217;s ability to expand beyond melanoma into other tumor types and to realize growth opportunities beyond oncology; the Company&#8217;s ability to grow and advance its clinical pipeline; the estimated size of the patient
    populations for the Company&#8217;s product candidates; expectations regarding sales growth; expectations regarding the design, progress, timing, enrollment, randomization, scope, expansion, and results of the Company&#8217;s and its collaborators&#8217; existing and
    planned clinical trials; the timing and sufficiency of clinical trial outcomes to support potential approval of any of the Company&#8217;s product candidates or those of, or combined with, its collaboration partners; the expected submission of clinical trial
    applications or investigational new drug applications; the flexibility provided by the Company&#8217;s balance sheet; the potential regulatory approval, and expected clinical benefits and availability of the Company&#8217;s product candidates. Any forward-looking
    statements are based on management&#8217;s current expectations and beliefs of future events and are subject to a number of risks and uncertainties that could cause actual events or results to differ materially and adversely from those set forth in or
    implied by such forward-looking statements, many of which are beyond the Company&#8217;s control. These risks and uncertainties include, but are not limited to, the impact of worsening macroeconomic conditions, including as a result of health epidemics or
    pandemics, war in Ukraine, the conflict in the Middle East, or global geopolitical tension, on the Company&#8217;s business, financial position, strategy and anticipated milestones, including Immunocore&#8217;s ability to conduct ongoing and planned clinical
    trials; the Company&#8217;s ability to obtain a clinical supply of current or future product candidates or commercial supply of KIMMTRAK or any future approved products; the Company&#8217;s ability to obtain and maintain regulatory approval of KIMMTRAK and its
    other product candidates; the Company&#8217;s ability and plans in continuing to establish and expand a commercial infrastructure and to successfully launch, market and sell KIMMTRAK and any future approved products; the Company&#8217;s ability to successfully
    expand the approved indications for KIMMTRAK or obtain marketing approval for KIMMTRAK in additional geographies in the future; the delay of any current or planned clinical trials, whether due to patient enrollment delays or otherwise; the Company&#8217;s
    ability to successfully demonstrate the safety and efficacy of its product candidates and gain approval of its product candidates on a timely basis, if at all; competition with respect to market opportunities; unexpected safety or efficacy data
    observed during preclinical studies or clinical trials; actions of regulatory agencies, which may affect the initiation, timing and progress of clinical trials or future regulatory approval; Immunocore&#8217;s need for and ability to obtain additional
    funding, on favorable terms or at all, including as a result of worsening macroeconomic conditions, including changes in inflation and interest rates and unfavorable general market conditions, and the impacts thereon of the war in Ukraine, the conflict
    in the Middle East, and global geopolitical tension; Immunocore&#8217;s ability to obtain, maintain and enforce intellectual property protection for KIMMTRAK or any of its product candidates it or its collaborators are developing; and the success of
    Immunocore&#8217;s current and future collaborations, partnerships or licensing arrangements. These and other risks and uncertainties are described in greater detail in the section titled "Risk Factors" in Immunocore&#8217;s filings with the Securities and
    Exchange Commission, including Immunocore&#8217;s most recent Annual Report on Form 10-K for the year ended December 31, 2025 filed with the Securities and Exchange Commission on February 25, 2026, as well as discussions of potential risks, uncertainties,
    and other important factors in the Company&#8217;s subsequent filings with the SEC. All information in this press release is as of the date of the release, and the Company undertakes no duty to update this information, except as required by law.</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;">
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">Contact Information</div>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Immunocore</div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">S&#233;bastien Desprez, Head of Communications</div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">T:<font style="font-family: 'Times New Roman';">&#160;</font>+44 (0) 7458030732</div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">E: <font style="font-family: 'Times New Roman';"><u>sebastien.desprez@immunocore.com</u></font></div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Follow on LinkedIn: @Immunocore</div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Investor Relations</div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Clayton Robertson / Morgan Morse</div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">T: +1 (215) 384-4781</div>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">E: <font style="font-family: 'Times New Roman';"><u>ir@immunocore.com</u></font></div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">Immunocore Holdings plc</div>
  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">Condensed Consolidated Statement of Operations</div>
  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">Fourth Quarter and Year Ended <font style="font-family: 'Times New Roman';">December 31, 2025</font> and <font style="font-family: 'Times New Roman';">2024</font></div>
  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">(In thousands, except share and per share data)</div>
  <table cellspacing="0" cellpadding="0" class="cfttable" id="z8855cd1168364b4e99a46cf96fbfb1a5" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" colspan="6" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Quarter Ended</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" colspan="6" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Year Ended</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: top; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">December 31, 2025</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: top; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">December 31, 2024</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: top; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">December 31, 2025</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: top; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">December 31, 2024</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Revenue from sale of therapies, net</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">104,478</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">84,052</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">400,016</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">309,989</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 52%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Collaboration revenue</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">213</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">Total revenue</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">104,478</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">84,052</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">400,016</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">310,202</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 52%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Cost of revenue from sale of therapies</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(2,703</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(330</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(5,087</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(2,731</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Research and development expense</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(78,821</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(60,850</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(274,869</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(222,151</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 52%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Selling, general, &amp; administrative expense</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(42,645</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(42,324</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(165,413</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(155,781</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">Loss from operations</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">(19,691</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">(19,452</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">(45,353</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">(70,461</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 52%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Interest income</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">3,906</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">5,173</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">16,476</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">25,618</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Interest expense</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(3,053</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(7,038</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(12,166</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(18,844</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 52%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Foreign currency (loss) gain</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(1,460</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(4,497</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">2,215</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(3,448</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Other income, net</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">4,504</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">993</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">19,728</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">14,198</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 52%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">Net income (loss) before income taxes</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">(15,794</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">(24,821</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">(19,100</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">(52,937</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Income tax (expense) benefit</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(14,266</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">1,050</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(16,414</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">1,850</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 52%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">Net loss</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">(30,060</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">(23,771</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">(35,514</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">(51,087</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 52%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">Basic and diluted net loss per share</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">(0.60</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">(0.47</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">(0.71</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">(1.02</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 52%; color: rgb(0, 0, 0); font-size: 10pt; padding-bottom: 4px;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-style: italic;">Basic and diluted weighted-average number of shares outstanding</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="font-family: 'Times New Roman'; font-style: italic;">50,465,586</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="font-family: 'Times New Roman'; font-style: italic;">50,046,748</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="font-family: 'Times New Roman'; font-style: italic;">50,345,666</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="font-family: 'Times New Roman'; font-style: italic;">49,991,064</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt; padding-bottom: 4px;">&#160;</td>
      </tr>

  </table>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><a name="Section3"></a>Immunocore Holdings plc</div>
  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">Condensed Consolidated Balance Sheets</div>
  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">As of December 31,</div>
  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">(In thousands)</div>
  <table cellspacing="0" cellpadding="0" class="cfttable" id="zc838f39ce54e48a3945c06e4e495e608" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">December 31, 2025</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">December 31, 2024</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">ASSETS</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: middle; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: middle; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">Current assets</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: middle; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: middle; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Cash and cash equivalents</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">467,709</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">455,731</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Marketable securities</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">396,444</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">364,645</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Accounts receivable, net</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">73,977</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">63,009</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Prepaid expenses and other current assets</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">50,055</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">41,033</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Tax receivable</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">1,815</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Inventory, net</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">6,742</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">5,446</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">Total current assets</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">996,742</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">929,864</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Property and equipment, net</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">11,462</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">10,092</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Operating lease right of use assets, net</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">38,783</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">37,643</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Deferred tax assets, net</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">14,790</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Other non-current assets</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">20,282</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">17,117</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">Total assets</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">1,067,269</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">1,009,506</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">Liabilities and shareholders&#8217; equity</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">Current liabilities</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Accounts payable</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">24,364</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">25,100</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Accrued expenses and other current liabilities</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">219,744</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">185,534</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Deferred revenue, current</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">583</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Operating lease liabilities, current</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">2,006</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">1,547</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">Total current liabilities</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">246,697</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">212,181</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Deferred revenue, non-current</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">4,858</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">5,434</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Operating lease liabilities, non-current</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">41,556</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">40,162</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Interest-bearing loans and borrowings</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">393,125</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">391,013</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">Total liabilities</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">686,236</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">648,790</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">Shareholders' equity</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Ordinary shares</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">136</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">135</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Deferred shares</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">1</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">1</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Additional paid-in capital</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">1,240,255</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">1,190,104</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Accumulated deficit</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(831,275</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(795,761</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Accumulated other comprehensive loss</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(28,084</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(33,763</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">Total shareholders' equity</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">381,033</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">360,716</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">Total liabilities and shareholders' equity</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">1,067,269</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">1,009,506</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>

  </table>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><a name="Section4"></a><img src="image00001.jpg">
    <div><br>
    </div>
    Immunocore Holdings plc</div>
  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">Summary Condensed Consolidated Statements of Cash Flows</div>
  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">For the Years Ended <font style="font-family: 'Times New Roman';">December 31,</font></div>
  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">(In thousands)</div>
  <table cellspacing="0" cellpadding="0" class="cfttable" id="zfd878b7820dc4b69a75193d2dfd780a7" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"> 2025</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">2024</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: middle; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: middle; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Cash and cash equivalents at beginning of the year</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">455,731</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">442,626</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Net cash (used in) provided by operating activities</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(10,712</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">26,061</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Net cash used in investing activities</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(16,340</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(355,129</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Net cash provided by financing activities</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">12,371</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">343,881</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman';">Net foreign exchange difference on cash held</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">26,659</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">(1,708</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">Cash and cash equivalents at end of the year</div>
        </td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">467,709</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
        <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
        </td>
        <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 10pt;">
          <div style="font-family: 'Times New Roman'; font-weight: bold;">455,731</div>
        </td>
        <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
      </tr>

  </table>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;"><br>
  </div>
  <div style="color: rgb(0, 0, 0); font-size: 10pt;">
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 25%; vertical-align: top; font-size: 10pt;"><img src="image00002.jpg"></td>
          <td style="width: 25%; vertical-align: top; font-size: 10pt;"><img src="image00003.jpg"></td>
          <td style="width: 50%; vertical-align: bottom; font-size: 10pt; text-align: right;">
            <div style="color: rgb(0, 59, 127); font-family: 'Times New Roman'; font-size: 8pt;">Page 13 of 13</div>
          </td>
        </tr>

    </table>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
  <font style="color: rgb(0, 0, 0); font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>imcr-20260225.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.10.1.5333 Broadridge-->
<xs:schema targetNamespace="http://immunocore.com./20260225" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:imcr="http://immunocore.com./20260225" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:srt-types="http://fasb.org/srt-types/2025">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="imcr-20260225_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="imcr-20260225_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="imcr-20260225_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://immunocore.com./role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2025" schemaLocation="https://xbrl.sec.gov/exch/2025/exch-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2025" schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2025" schemaLocation="https://xbrl.sec.gov/sic/2025/sic-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2025" schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
  <xs:element name="AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember" id="imcr_AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="OrdinaryShareNominalValue0002PerShareMember" id="imcr_OrdinaryShareNominalValue0002PerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>imcr-20260225_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.10.1.5333 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://immunocore.com./role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="imcr-20260225.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://immunocore.com./role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="definition: EntityListingsLineItems to DocumentType" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="definition: EntityListingsLineItems to AmendmentFlag" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="definition: EntityListingsLineItems to DocumentPeriodEndDate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalYearFocus" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="definition: EntityListingsLineItems to EntityFileNumber" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="definition: EntityListingsLineItems to EntityRegistrantName" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="definition: EntityListingsLineItems to EntityCentralIndexKey" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="definition: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="definition: EntityListingsLineItems to EntityTaxIdentificationNumber" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine1" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine2" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine3" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="definition: EntityListingsLineItems to EntityAddressCityOrTown" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="definition: EntityListingsLineItems to EntityAddressStateOrProvince" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="definition: EntityListingsLineItems to EntityAddressCountry" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="definition: EntityListingsLineItems to EntityAddressPostalZipCode" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="definition: EntityListingsLineItems to CityAreaCode" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="definition: EntityListingsLineItems to LocalPhoneNumber" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="definition: EntityListingsLineItems to Security12bTitle" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="definition: EntityListingsLineItems to TradingSymbol" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="definition: EntityListingsLineItems to NoTradingSymbolFlag" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="definition: EntityListingsLineItems to SecurityExchangeName" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="definition: EntityListingsLineItems to EntityEmergingGrowthCompany" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="definition: EntityListingsLineItems to WrittenCommunications" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="definition: EntityListingsLineItems to SolicitingMaterial" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementTenderOffer" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EntityListingsLineItems" xlink:to="EntityListingsTable" xlink:title="definition: EntityListingsLineItems to EntityListingsTable" order="29.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: EntityListingsTable to StatementClassOfStockAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="imcr-20260225.xsd#imcr_AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember" xlink:label="AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember" xlink:title="AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember" xlink:title="definition: ClassOfStockDomain to AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="imcr-20260225.xsd#imcr_OrdinaryShareNominalValue0002PerShareMember" xlink:label="OrdinaryShareNominalValue0002PerShareMember" xlink:title="OrdinaryShareNominalValue0002PerShareMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="OrdinaryShareNominalValue0002PerShareMember" xlink:title="definition: ClassOfStockDomain to OrdinaryShareNominalValue0002PerShareMember" order="2.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>imcr-20260225_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.10.1.5333 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDomain" xml:lang="en-US" id="us-gaap_ClassOfStockDomain">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain" xlink:title="label: ClassOfStockDomain to us-gaap_ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementClassOfStockAxis" xml:lang="en-US" id="us-gaap_StatementClassOfStockAxis">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:title="label: StatementClassOfStockAxis to us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsTable" xml:lang="en-US" id="dei_EntityListingsTable">Entity Listings [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsTable" xlink:to="dei_EntityListingsTable" xlink:title="label: EntityListingsTable to dei_EntityListingsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsLineItems" xml:lang="en-US" id="dei_EntityListingsLineItems">Entity Listings [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsLineItems" xlink:to="dei_EntityListingsLineItems" xlink:title="label: EntityListingsLineItems to dei_EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
    <link:loc xlink:type="locator" xlink:href="imcr-20260225.xsd#imcr_AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember" xlink:label="AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember" xlink:title="AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember" />
    <link:label xlink:type="resource" xlink:label="imcr_AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="imcr_AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember_lbl1" xml:lang="en-US" id="imcr_AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember_lbl1">American Depositary Shares, each representing one ordinary share, nominal value 0.002 per share [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember" xlink:to="imcr_AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember_lbl1" xlink:title="label: AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember to imcr_AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="imcr-20260225.xsd#imcr_OrdinaryShareNominalValue0002PerShareMember" xlink:label="OrdinaryShareNominalValue0002PerShareMember" xlink:title="OrdinaryShareNominalValue0002PerShareMember" />
    <link:label xlink:type="resource" xlink:label="imcr_OrdinaryShareNominalValue0002PerShareMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="imcr_OrdinaryShareNominalValue0002PerShareMember_lbl1" xml:lang="en-US" id="imcr_OrdinaryShareNominalValue0002PerShareMember_lbl1">Ordinary share, nominal value 0.002 per share* [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrdinaryShareNominalValue0002PerShareMember" xlink:to="imcr_OrdinaryShareNominalValue0002PerShareMember_lbl1" xlink:title="label: OrdinaryShareNominalValue0002PerShareMember to imcr_OrdinaryShareNominalValue0002PerShareMember_lbl1" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>imcr-20260225_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.10.1.5333 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://immunocore.com./role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="imcr-20260225.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://immunocore.com./role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="imcr-20260225.xsd#imcr_AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember" xlink:label="AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember" xlink:title="AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember" xlink:title="presentation: ClassOfStockDomain to AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="imcr-20260225.xsd#imcr_OrdinaryShareNominalValue0002PerShareMember" xlink:label="OrdinaryShareNominalValue0002PerShareMember" xlink:title="OrdinaryShareNominalValue0002PerShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="OrdinaryShareNominalValue0002PerShareMember" xlink:title="presentation: ClassOfStockDomain to OrdinaryShareNominalValue0002PerShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: EntityListingsTable to StatementClassOfStockAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="presentation: EntityListingsLineItems to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="presentation: EntityListingsLineItems to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: EntityListingsLineItems to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="presentation: EntityListingsLineItems to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="presentation: EntityListingsLineItems to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="presentation: EntityListingsLineItems to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: EntityListingsLineItems to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: EntityListingsLineItems to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: EntityListingsLineItems to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="presentation: EntityListingsLineItems to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: EntityListingsLineItems to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="presentation: EntityListingsLineItems to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="presentation: EntityListingsLineItems to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="presentation: EntityListingsLineItems to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="presentation: EntityListingsLineItems to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: EntityListingsLineItems to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="presentation: EntityListingsLineItems to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: EntityListingsLineItems to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="presentation: EntityListingsLineItems to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="presentation: EntityListingsLineItems to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="EntityListingsLineItems" xlink:title="presentation: EntityListingsTable to EntityListingsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityListingsTable" xlink:title="presentation: CoverAbstract to EntityListingsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  D /,# 2(  A$! Q$!_\0
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M?2N9&K?%X#_D6_#?_@2W_P 76MX6U'XCSZ];1^)-$T2UTEMWG36TY:1?E.W
MW'^+:.G0FHJ.JXM2FFO5%05-2347]S._HHHKB.H**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
&*** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  \ ((# 2(  A$! Q$!_\0
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%*DH__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image00003.jpg
<TEXT>
begin 644 image00003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  Y )L# 2(  A$! Q$!_\0
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MBW[P,@,"&P,@@CM60/!UNT7DS7ES)!%&8[1#M'V8;@V0<<G*KUSP*U]&TO\
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MLMPME#"B(3:G<;EE;(9PX(]..?K4$?@W4(K""%GM;JY$9B^TR$HT!\PL'3:
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-[A9!1112&%%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 25, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 25,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39992<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Immunocore Holdings plc<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001671927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">X0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">92 Park Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Milton Park Abingdon<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Oxfordshire<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">GB<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">OX14 4RY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">1235 438600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=imcr_AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember', window );">American Depositary Shares, each representing one ordinary share, nominal value 0.002 per share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares, each representing one ordinary share, nominal value 0.002 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IMCR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=imcr_OrdinaryShareNominalValue0002PerShareMember', window );">Ordinary share, nominal value 0.002 per share* [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary share, nominal value 0.002 per share*<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">*<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=imcr_AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=imcr_AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=imcr_OrdinaryShareNominalValue0002PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=imcr_OrdinaryShareNominalValue0002PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ef20066378_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://immunocore.com./role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ef20066378_8k.htm">ef20066378_8k.htm</File>
    <File>imcr-20260225.xsd</File>
    <File>imcr-20260225_def.xml</File>
    <File>imcr-20260225_lab.xml</File>
    <File>imcr-20260225_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ef20066378_8k.htm": {
   "nsprefix": "imcr",
   "nsuri": "http://immunocore.com./20260225",
   "dts": {
    "inline": {
     "local": [
      "ef20066378_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "imcr-20260225.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/exch/2025/exch-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/sic/2025/sic-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "imcr-20260225_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "imcr-20260225_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "imcr-20260225_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 8,
    "http://xbrl.sec.gov/dei/2025": 8
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 35,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 26
   },
   "report": {
    "R1": {
     "role": "http://immunocore.com./role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20260225to20260225",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20066378_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20260225to20260225",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20066378_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "imcr_AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://immunocore.com./20260225",
     "localname": "AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "American Depositary Shares, each representing one ordinary share, nominal value 0.002 per share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "imcr_OrdinaryShareNominalValue0002PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://immunocore.com./20260225",
     "localname": "OrdinaryShareNominalValue0002PerShareMember",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary share, nominal value 0.002 per share* [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001140361-26-006721-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-26-006721-xbrl.zip
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MS]I[V.D/H7NM75 3:%(E)QI44LS.AR#:EF$7,_I6:I?,Z-K17=3Y?(X,4VL
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M+C]6W20)&\N_O:P?M?\-4$L#!!0    ( - [65S]#G<;;4(  )Z% P 5
M968R,# V-C,W.%]E>#DY+3$N:'1M[7UK=]M&TN;W]YSW/_0JR8RT RH "-XL
MQV=EV1YKQ[(]DI)YY].>!M 4,08!!A?9RJ_?JNK&C:2ND4R ZLR<1**(1E^J
MGKI7OYQE\_#5?_\78R]G@OOT$_R<!5DH7KW\6?Y7??B_>CWV(?!$E J?9?$+
M]CJ)N9\$_H5@[X*(1U[ 0_8F2+TP3O-$R,?HGS>QE\]%E#$O$3R#Q_,TB"[J
M WP^_30-0L'LP;YE[EO[@WZ_7QO@*%Y<)<'%+&/69#)@/6:;]K#^?*\G5_&S
M6L9+-_:OF'OAQ6&<_++SPY3^V6%I=A6*7W:F<93UIGP>A%<OV%_/@[E(V4?Q
ME9W&<Q[]]8#1W]/@#_&"6>8B.V"9^);U>!A<1"]8**;P"8W\@OU@TC\'._+]
M^&#Q$O6-Y,+=-0V&_]];'7GG%4P:/U2GD+ H3F?<A^?5#SN,W@OCP0Z*I%S#
M3."&O&#.XMO*;)C+O2\729Q'?F_Y3_6ER"$/V)PG%T'4PY6]8#S/XO*C1+Y$
M?N;&B2]@K"B.!,S\_JN5'WQ5,W?CT(=AWGZ;!6Z0R>.>3/8MM2$/V<R7;J((
MH=I3/[@L1KEU[?W]_J(ZW#5ONP_1K%OL7WZPAN;!\7R>1[$7)X(E8A$G60I?
MSI-LQG[/>0+38CSRV30/0W8E>(+D/F#3DLD2D>8A/(-?6B3Q9>##5#ASD:U$
MFK)\X0.;O?P95KZR!??>R'6#K-O'1]PS>LL+%F3P"@\F\X_CDY/ST\-_L-U,
MN/ Z/LW310]^CO;8/QT6"2 3'L+0\93]:)G._H#!&\,@CFB+?G1,<]\L/YK&
MR=+6'C#Q;2&\C,UCH&^>(3@EXE)$N6# 15^SF23.("+@V9Z-/7_[^FWO\(2)
M*(G#4$)T/%^$(I-[EP5>L"#$MMY+S/T: )%F\2($2F- 95QM'7R%IPPV-+S"
M'^SW6[93GT\/3]ZR:0(<. M2$%@S#O^V?K;E)F0Q<P7PHDAQ*CY1BMP"X/Q$
M (42S>+G\25/ BXI,\R!TCP84R0&?1!$088<3H/27L]X..V%P53)4UBUB'QX
M SSE!\CF;/?XY*CWV;(&1WO;L]^'OA\@$<)>J*UF[X]_NVVSMV?]1SR=&7#(
MZ8R)W_/@$N M4H@/ NL+T),+ZE(JO#R!?5+0-QXZ^W8%??3A&^&)N0L2I6\9
M!'9;M$=Q-!7 7)Z C0(\SV*?7QGLG7 3D*)7H$PRGK'Q"],$B'M[;C +?F2?
M3]C?3\Z_TR[\)T^S8'KU@!6OF\K.J]V&4G3+H#NO/OW/NT^G;\[>'Y^^-=C;
MZ")$^OD+GR\.V.GAFX^?3@WV6431OOKL[X?'Y^_?GIZ]_O7T[P8[\?<-]NL9
M4,U J5.UK05FVV,O\U>5)O/?_X7_D_KZ>U!V0(BF;!%Z;/<C3WW^^PL&.'6Z
MQW;_\L/8MNLZ$'U@'3"0R]E,,/7W(Q!$/+I2?P1HRU\!1J)\FHL$U2"@!PZJ
MOQO$F?!F$>S7Q16)+WB*+8 #A$A0DN.:?1$&E_+7## \!1U@#G+^4K" I@&"
M/P^EX)\+'Z0>Z%&(,PF'7X"VKN![J&D)%N<9O$.DI$: ; R(+PFJ"R /@"P]
M *\\93[("D"O5&X,S@0U:7JG*/]H2,J%/T>@L7N(:*@0KJA[4[5!:U1%4F6D
M8%AA>*.N)_JK>N)^1WGA'+9"$0E(2=AK,8^C%(X794)%)J#4H6*3S^4A60/X
M6X3 2<>O-I&@LE S7Z;YHE@ $$V&%% L@A8$^L\!0PVH5QAA5F/6Z1Q(!L"/
MU/V1<_#R9QCQU3KMM:EE&@S,6?B N5? >+2&'!2"*SK BS!V<36$_FR!.@6J
MJC%P[S& O9*7!E%(L2U!BF)RP8GPB6"!5R+2,"+8\+D 0(!-!XI%,L?G4Q0;
M0:8T0N"!62(*;:</O ./IB]8H3?BO [//YT8DKYK7 ;RI]A.Y&!K=) RU&*\
M*P_D%IPSL"X>BR3.SZ?'9R>]D[<?>GW38@*D72Z9<4EWF@9)FO5(]RSFO@^X
M5BJO\!5</G"RD-^"4^:10$XLUTIK8+MJ"7@$<Q[ NF'&L*'>%]JGFA:LQJ17
MDS:&I)*!$BB9KJX0RUT E$A0'*5Y<HF"F^U^.MN3FDM=1<9!@0QC6'XQ*J+J
M-G C+ I.+R<_$5#F)>(B89H'NX3<!/"\$'1 KKC"':A1(CP2P]X U.5S!+RK
M!4Q(DB-21 FYW$MBP+ Y0&, 9R4W5LD$2:?[\CR.H^OVNLDLTI AV%>ZI3RT
M:1+/Z8MQ=!$3;=<T^(]G1Q^.\%$0*D@M7CPC<YYHI&XF2+*#C^LDC2/@UQIJ
M?_F^4O6OM'XR0WJ'IKU>_]\&XB',BB_@!%(%)$@Y$B!9O$!O"8(BZKR*>.+(
M(^%O*.PJR(^.TH_A $0*1(=[I9@938DIB%IE88 2+>1+^5P*2Z!&);-A"-)D
MZ3E)OY+GI8Q&4*B)].I4;H:-?59;<@F0(+QB!#V8*W),.A.(](6#1PY7* 73
M4'P+W"!$\8!S_(823>"7TG(M:5?I0:F _\)]1N]-:=,$E5A1+A_2J4"5 M!-
M10U@@$RF,3QCL)JS;<;QR[ [?NZ1^"<(AX-1Y*44)2(^Y>T9&(5Z>A_5>ZWO
M+^6!SU[S6? ?SOXO2 @>&NSH[2=\?S5'I6KO%VKPIQRD=A+$"1XTBB9RPP2I
MHD?2^^CL<7M@)- -JUV0.&@ :*(6 QJNDCU?1<VYP[Z(*XD\Z)U0O$1;X8H+
M_ A&)#)6#$% !I^O:K+[[%]"R5.8JI=CI"!6(AD(&W2>9,XN8HF#/J@^8;Q8
M4KEG8+$!$[$4Z"J8PB*BK*9\*_!GJ&:D^SM_BKI56 -'* B]0>KKQ\8-QP/-
M9J7G&(1_0<WJ$_AS%L^+-\%Q\#3]9>?UZ>=WGT$ZO4X$_W((_ZK/H7C! K[0
M<_$;/3[-T-G.PZ_\*KUFF&*(ZT(':E0Y+XH5,!/C!5\#/YOA!,V?"K=^3WUF
M'K!"J[7O&5JH[P[ QRU[^3@ LLIHUV *&*OOT.O[;V09I.YWTHSZIS*CWL,0
M(0Z3LMT@\L+<)W4C!H5S 3IM[),)VGI 7>,IN?L>57&\4VESMGZYUZQCO:4L
MU;X!V_VG0S_LH>6=D3&4%5*A-,EV80R2S,.#,L"@)/4> P60M)-25ROC#Z5X
M^@HXVPQ&&/<2(3NOR)>12"WZQ[&S;S5"&/*M<P!%HDXEKIS]PE>CUJAF]E6
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M25LMK1X!IE&6W</9H3O6WIV5UENLIRZJKI.1.^T+CP_MB7!&P@$!.1DXP]'
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M<['-RL]C[H]_4I>[722@I[ ^0HZSS]Y&*76[FF-F(.(C]SS44P$>JUQ!N=L
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M=33K:-9Y@+K6MS3K7+OZ9Q6LQ;+G5/#$FZDKSZO+4K&Y?Y3J8*UV8G7!B07
M-AH;8[O=R-:.G=JTZK!I#M \W1F>'IK&>-!N&[D=.Z5Y6O-T1WC:'CG&>/B,
MJALU4VNFWGJFMFW#&FCMNZ7>AY:4/9_!>=)->.JR.8/]A<]AJMR?!U% MR &
MEZ(EK@==O])"M&M'_<JN8QM#IX4-0A^)?#NKL6B>U3Q[ \_VV]BA5?.LYEG-
ML^MYUAH.#&>+BT4UTVJFW3ZF'0R,QH6+FFEUXL%=B@X^Q&DJD]/C-5<#;@3G
M-NTPU"[0;KA U]+SKC4QAI-V V%K-V_3&LZF^41S?L<YWWE.1>B:\S7G:\XG
M-^/ Z _:[;%H[>9ISM><WUW.'YF&,]3:_A-P_M94XA_C78,BS5@0>?%\TQD.
M70*R+D'44_L1^\;$;'?WG*<[+4WUSY7J!X8U:K=>K:F^[?O8/:JWAH8STF"O
MR?YYD;T],(96N]OL/ORXGE6DMV;TM".O>],N$>WDZ8:3!_LS&:9VY78@&VW3
M#*!9NC,L/3+,?KOUBG9LE&9IS=(=86G+-JQANTWD=NR4YFG-TUWAZ;$Q=MI=
MK-6.G7HF@=-W<2+@^PQ96$3>%=L-XS3=8Q<\B'045;L8'X0QAC-L=V^I;5<(
M-.MTE'4<PYGH_LN:=33KW)=N;,.VVMTX1(=SV[Z/W:/ZW;[A..UVNVZEH;:V
MS+FM<>)/>!65RHPU6"2R-O8XV+3'9V.=$#:]\(WU2VB'G\<Q!F:[_6&M9!>-
M AH%M@@%)I-VIZ.TDEDT!F@,V"(,L";&R&ZW+=5*?M$PH&%@FV# ,:R)AH%M
MO;5[;97T1U%4#A?Q;U=,XT04'V;\F[['6[MH'X GUW0Q&ABC2;N]#AO8%AWZ
MTQSV6!QF.ZV_M%!SF.:P#G,8F,N6^9S3O#2':0Y[4@X;V,:D_YRSP=K3T:I3
M\?[CTFAENZHT' W:2$P#'?K7GC[MZ2L3U1W#;GF!V^: I_69NAI+-):T!DLL
MPVSY?>JM9!>- AH%M@@%=K&KG-5NQ[[6*#26:"QI/Y98QEAK%-\M#:$5%[E?
MFYN .0EMQ,8M1+T->#1__%-'NZ7W7:YWB?=-PVQY;X$-W(#9RDB4!@P-&!O?
MJ5V[;XQ&[<X#T8"A 4,#1DMV:K<_, 9=].!HP-" H0%C$UDZEF&.VYVETPW
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M8&MK0VX=#[8^PYYDFHNZ=R::B]IV8EN2:K!6*3JKM8'_JVX KT.N;63P-@M
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M_5\O?W9C_XI^F&7S$'[X_U!+ P04    " #0.UE<YU?6 ^@#  !:$@  $0
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MZV'C76949-8%Z,-VX'5BKRWG931(HU'JF9@?V\0YT3-'\C=;BK0RQ_#-547
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M;SZ!-Q_#PY]J^YP_FTR*Q +XT<L,E-P-?U/_I65U7/U0_]7DT_]02P,$%
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MV6'^WI$MQF7?:&<S.&2%'[ILJ[F^98_X_Q=5-D7%_Z\T^3]02P,$%     @
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MS]$2RU\[]5L3K1@9L0*,RW*H0JNR$ J,*0FX7+D;D1#Y2%#Z#&)($="W?L4
MM3H8 "YGOI10]97!8$GEW.5ZW1.%0JH0^\G376/Q6@,ZG$YSU_'E0!DR&]!E
M+50F6%D3-HM*&R[7ZS3_!XPM(:VLD$*X62<&^!FII8SLOIHQV%7*.59-T)T'
M5LO"OL/CJH6FSO=A:?-[6G)A,[T117OD/&TH'RQIX$A/3KYKYN+$L_%5O#!N
MTR+^B!>LO?\/4$L! A0#%     @ T#M97 J)\B'+%   UXT  !$
M     ( !     &5F,C P-C8S-SA?.&LN:'1M4$L! A0#%     @ T#M97/T.
M=QMM0@  GH4# !4              ( !^A0  &5F,C P-C8S-SA?97@Y.2TQ
M+FAT;5!+ 0(4 Q0    ( - [65SG5]8#Z ,  %H2   1              "
M 9I7  !I;6-R+3(P,C8P,C(U+GAS9%!+ 0(4 Q0    ( - [65P7>D=O# <
M "%&   5              "  ;%;  !I;6-R+3(P,C8P,C(U7V1E9BYX;6Q0
M2P$"% ,4    " #0.UE<O!?"(58*  "K:@  %0              @ 'P8@
M:6UC<BTR,#(V,#(R-5]L86(N>&UL4$L! A0#%     @ T#M97,)]>)\5!P
MK$X  !4              ( !>6T  &EM8W(M,C R-C R,C5?<')E+GAM;%!+
4!08     !@ & (H!  #!=      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>ef20066378_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:imcr="http://immunocore.com./20260225"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="imcr-20260225.xsd" xlink:type="simple"/>
    <context id="c20260225to20260225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671927</identifier>
        </entity>
        <period>
            <startDate>2026-02-25</startDate>
            <endDate>2026-02-25</endDate>
        </period>
    </context>
    <context id="c20260225to20260225_StatementClassOfStockAxis_OrdinaryShareNominalValue0002PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671927</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">imcr:OrdinaryShareNominalValue0002PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-25</startDate>
            <endDate>2026-02-25</endDate>
        </period>
    </context>
    <context id="c20260225to20260225_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671927</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">imcr:AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-25</startDate>
            <endDate>2026-02-25</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20260225to20260225"
      id="Fact_250538e4e821412e857745bc004b128e">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20260225to20260225"
      id="Fact_aaa86321ccf34829809414b68f47ebe3">0001671927</dei:EntityCentralIndexKey>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20260225to20260225"
      id="Fact_86c07db62f8542e7b5266aa6f5508736">X0</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20260225to20260225"
      id="Fact_7179d905fcd44be2b3fd3063d7f063d1">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:Security12bTitle
      contextRef="c20260225to20260225_StatementClassOfStockAxis_OrdinaryShareNominalValue0002PerShareMember"
      id="Fact_c7bfe0d81bf84bf5a97521cc0706e5c2">Ordinary share, nominal value 0.002 per share*</dei:Security12bTitle>
    <dei:Security12bTitle
      contextRef="c20260225to20260225_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember"
      id="Fact_0dd69d95358a451387bd6a571bd44601">American Depositary Shares, each representing one ordinary share, nominal value 0.002 per share</dei:Security12bTitle>
    <dei:SecurityExchangeName
      contextRef="c20260225to20260225_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember"
      id="Fact_f5b67d1627e34a4bbe6fd8cefafe48ad">NASDAQ</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="c20260225to20260225_StatementClassOfStockAxis_OrdinaryShareNominalValue0002PerShareMember"
      id="Fact_e83551897f1e440e9796e1c0055b6589">NASDAQ</dei:SecurityExchangeName>
    <dei:DocumentType
      contextRef="c20260225to20260225"
      id="Fact_e23b7feba4c04796a5574f4a8af8c894">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20260225to20260225"
      id="Fact_f302ce8a6b1c4c3997c4675c23c8e08b">2026-02-25</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20260225to20260225"
      id="Fact_93cc693ce62a43b09d93566efbbbe079">Immunocore Holdings plc</dei:EntityRegistrantName>
    <dei:EntityFileNumber
      contextRef="c20260225to20260225"
      id="Fact_d788b2009e2d4a44bf2c87af794fd482">001-39992</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20260225to20260225"
      id="Fact_d5a72c77266746dab47419523eb1df5c">92 Park Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20260225to20260225"
      id="Fact_53ca2562655b41c1ad778b400382b2d9">Milton Park Abingdon</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20260225to20260225"
      id="Fact_d2b5b2226fda4b339e97303895c86c7e">Oxfordshire</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="c20260225to20260225"
      id="Fact_8d3af2bb6356495c9cc65a6dbe8d6bb4">GB</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="c20260225to20260225"
      id="Fact_bb8c106e83c849a3887c88dd687313ca">OX14 4RY</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20260225to20260225"
      id="Fact_ce298ce5ed4e435cbaea2c44a8c9a761">44</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20260225to20260225"
      id="Fact_18f38d71fc25434d951736506b997daf">1235 438600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20260225to20260225"
      id="Fact_a90f31d7a32e4b719ed00dd335e70382">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20260225to20260225"
      id="Fact_1c28b9b01f6846228baffa5c5167350a">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20260225to20260225"
      id="Fact_becc57570dc24a858fb71d0f72e68a95">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20260225to20260225"
      id="Fact_2cbe863c27904828917a5ab056f8f822">false</dei:PreCommencementIssuerTenderOffer>
    <dei:TradingSymbol
      contextRef="c20260225to20260225_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingOneOrdinaryShareNominalValue0002PerShareMember"
      id="Fact_a9217c04979844f284d18665a6b3393e">IMCR</dei:TradingSymbol>
    <dei:TradingSymbol
      contextRef="c20260225to20260225_StatementClassOfStockAxis_OrdinaryShareNominalValue0002PerShareMember"
      id="Fact_433ceee7fb7d4e898fcd3dd8e70b2c40">*</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20260225to20260225"
      id="Fact_cd6b97acb2964620807e60199338d126">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
